Crossmark

Safety and efficacy of mavacamten for treatment of hypertrophic cardiomyopathy: a systematic review and meta-analysis of randomized clinical trials

Published Online: 2023-01-12

Authors

Rabiee Rad, Mehrdad

Ghasempour Dabaghi, Ghazal https://orcid.org/0000-0001-9850-874X
Habibi, Danial
License Information

Text and Data Mining valid from 2023-01-12

Version of Record valid from 2023-01-12
More Information

Article History

Received: 8 September 2022

Accepted: 30 December 2022

First Online: 12 January 2023

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current